Works matching IS 26882663 AND DT 2023 AND VI 4 AND IP 6
Results: 57
SARS‐CoV‐2 booster immunization: stimulating de novo B‐cell response and antibody generation.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.465
- By:
- Publication type:
- Article
STAT4 facilitates PD‐L1 level via IL‐12R/JAK2/STAT3 axis and predicts immunotherapy response in breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.464
- By:
- Publication type:
- Article
ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.463
- By:
- Publication type:
- Article
The role of mitochondrial dynamics in disease.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.462
- By:
- Publication type:
- Article
Long‐term immune response to Omicron‐specific mRNA vaccination in mice, hamsters, and nonhuman primates.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.460
- By:
- Publication type:
- Article
Urolithin A protects severe acute pancreatitis‐associated acute cardiac injury by regulating mitochondrial fatty acid oxidative metabolism in cardiomyocytes.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.459
- By:
- Publication type:
- Article
Identification of RP11‐770J1.4 as immune‐related lncRNA regulating the CTXN1–cGAS–STING axis in histologically lower‐grade glioma.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.458
- By:
- Publication type:
- Article
O‐GlcNAcylation: cellular physiology and therapeutic target for human diseases.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.456
- By:
- Publication type:
- Article
Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.455
- By:
- Publication type:
- Article
Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.454
- By:
- Publication type:
- Article
Activating the STING pathway to prevent dormant metastasis in lung adenocarcinoma.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.453
- By:
- Publication type:
- Article
Midnolin‐proteasome pathway for protein degradation.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.450
- By:
- Publication type:
- Article
Preoperative treatment of locally advanced rectal cancer: less is more.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.443
- By:
- Publication type:
- Article
Nrf2/PHB2 alleviates mitochondrial damage and protects against Staphylococcus aureus‐induced acute lung injury.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.448
- By:
- Publication type:
- Article
NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.447
- By:
- Publication type:
- Article
Receptor tyrosine kinases: biological functions and anticancer targeted therapy.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.446
- By:
- Publication type:
- Article
Role of the immune system in liver transplantation and its implications for therapeutic interventions.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.444
- By:
- Publication type:
- Article
BDH1‐mediated LRRC31 regulation dependent on histone lysine β‐hydroxybutyrylation to promote lung adenocarcinoma progression.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.449
- By:
- Publication type:
- Article
Transcription factor 19‐mediated epigenetic regulation of FOXM1/AURKB axis contributes to proliferation in clear cell renal carcinoma cells.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.442
- By:
- Publication type:
- Article
The determinants associated with zoonotic potential of influenza A viruses: BTN3A3 evasion mediated by residue mutation in the nucleoprotein.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.441
- By:
- Publication type:
- Article
FOXC1 restrains NF‐κB‐mediated interleukin‐1β transcription in breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.440
- By:
- Publication type:
- Article
Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.439
- By:
- Publication type:
- Article
Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition).
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.438
- By:
- Publication type:
- Article
Biomarkers and experimental models for cancer immunology investigation.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.437
- By:
- Publication type:
- Article
A cell‐penetrating peptide exerts therapeutic effects against ischemic stroke by mediating the lysosomal degradation of sirtuin 5.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.436
- By:
- Publication type:
- Article
A multicenter single‐arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2‐positive breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.435
- By:
- Publication type:
- Article
Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.434
- By:
- Publication type:
- Article
Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.433
- By:
- Publication type:
- Article
Single‐cell transcriptomic atlas of distinct early immune responses induced by SARS‐CoV‐2 Proto or its variants in rhesus monkey.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.432
- By:
- Publication type:
- Article
Progress in cancer neuroscience.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.431
- By:
- Publication type:
- Article
New discoveries on how DICER efficiently processes pre‐miRNA.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.430
- By:
- Publication type:
- Article
Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.429
- By:
- Publication type:
- Article
Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessation.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.428
- By:
- Publication type:
- Article
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.427
- By:
- Publication type:
- Article
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.426
- By:
- Publication type:
- Article
Cyclical endometrial repair and regeneration: Molecular mechanisms, diseases, and therapeutic interventions.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.425
- By:
- Publication type:
- Article
A novel Bruton's tyrosine kinase inhibitor JDB175 shows potent efficacy to suppress central nervous system lymphoma.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.424
- By:
- Publication type:
- Article
Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.422
- By:
- Publication type:
- Article
Potential therapies targeting nuclear metabolic regulation in cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.421
- By:
- Publication type:
- Article
Probiotics, prebiotics, and postbiotics in health and disease.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.420
- By:
- Publication type:
- Article
The pathogenesis and potential therapeutic targets in sepsis.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.418
- By:
- Publication type:
- Article
Microbiota in cancer: molecular mechanisms and therapeutic interventions.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.417
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.416
- By:
- Publication type:
- Article
Genome‐wide meta‐analysis and fine‐mapping prioritize potential causal variants and genes related to leprosy.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.415
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.414
- Publication type:
- Article
Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.413
- By:
- Publication type:
- Article
Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in mice.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.412
- By:
- Publication type:
- Article
Low‐dose exercise protects the heart against established myocardial infarction via IGF‐1‐upregulated CTRP9 in male mice.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.411
- By:
- Publication type:
- Article
The emerging role of exosomes in communication between the periphery and the central nervous system.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.410
- By:
- Publication type:
- Article
Methylation of ESR1 promoter induced by SNAI2–DNMT3B complex promotes epithelial–mesenchymal transition and correlates with poor prognosis in ERα‐positive breast cancers.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.403
- By:
- Publication type:
- Article